Pericardiectomy for constrictive pericarditis: short- and long-term outcomes in Sweden

Sebastian Sartipy1, Susanne J Nielsen1,2, Carl Johan Malm1,2

  • 1Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Insights

Pericardiectomy for constrictive pericarditis has a 5.1% 30-day mortality, with older age a risk factor. While long-term survival is poorer than the general population, comorbidities significantly influence outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Thoracic Surgery

Background:

  • Constrictive pericarditis, caused by pericardial fibrosis, restricts diastolic relaxation and can lead to heart failure.
  • Pericardiectomy is the only curative treatment for constrictive pericarditis.
  • Limited evidence exists on factors influencing outcomes after pericardiectomy.

Purpose of the Study:

  • To investigate short- and long-term outcomes following pericardiectomy for constrictive pericarditis.
  • To identify factors associated with variations in outcomes after this procedure.

Main Methods:

  • A nationwide Swedish study of all pericardiectomy procedures for constrictive pericarditis between 1997 and 2020.
  • Data sourced from the SWEDEHEART registry and two mandatory registries.
  • Analysis of short- and long-term survival, with comparison to an age- and sex-matched general population control group.

Main Results:

  • 175 patients (mean age 59 years) were included; 47% required extracorporeal circulation, and 26% had concomitant cardiac surgery.
  • 30-day mortality was 5.1%, linked to older age at surgery (p=0.008).
  • 22% of patients were readmitted for heart failure, associated with older age (p=0.02) and preoperative atrial fibrillation (p<0.001).
  • Univariable analysis showed poorer long-term survival in pericardiectomy patients versus controls (HR 2.55), but this was attenuated after multivariable adjustment (aHR 1.40).

Conclusions:

  • Pericardiectomy for constrictive pericarditis is a rare procedure with a notable early mortality risk.
  • A low proportion of patients experience heart failure readmission post-surgery.
  • Preoperative comorbidities significantly impact postoperative outcomes in patients undergoing pericardiectomy.
Abstract

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...